TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.050
+0.450 (12.50%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 6:43 PM EST
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $123.50 million as of December 20, 2024. Its market cap has increased by 18.20% in one year.
Market Cap
123.50M
Enterprise Value
135.66M
1-Year Change
18.20%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $123.50M, a decrease of -62.43%. That is a compound annual growth rate of -22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 123.50M | -44.46% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| American Well | 120.41M |
| Metagenomi | 116.39M |
| Cassava Sciences | 115.95M |
| Zomedica | 115.63M |
| Eupraxia Pharmaceuticals | 114.15M |
| Milestone Pharmaceuticals | 112.61M |
| TELA Bio | 112.26M |
| Cabaletta Bio | 111.93M |